8 results · 23ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Steerant™ Super Stiff Guidewire

FDA 510(k)
FDA Class 2 ·Cardiovascular

Symmetry Cobb

FDA UDI
ASPEN SURGICAL PRODUCTS, INC.·00887482001646·Symmetry® Curette, Cobb, Size 000, Tip 2.0 mm W...

Insulin Syringe, Insulin Syringe with Safety Retractable

FDA 510(k)
FDA Class 2 ·General Hospital

ELECTRIC HANDPIECE SYSTEM

FDA 510(k)
FDA Class 1 ·Dental

GE OEC 9800

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS INC.·Product code JAA·November 13, 2008

DEXTRUS 4137

FDA Adverse Event
Injury ·BIOTRONIK SE & CO. KG·Product code NVZ·August 19, 2011

EMAX 2 PLUS MOTOR

FDA Adverse Event
Malfunction ·DEPUY SYNTHES POWER TOOLS·Product code HBC·July 18, 2013

Brand Name: SenTiva" Product Name: VNS Therapy" SenTiva", Model 1000 Model/Catalog Number: 1000 Software Version: NA Product Description: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS), consists of an implantable VNS Therapy generator, lead, and external programming system used to change stimulation settings. The generator is an implantable, multi-programmable pulse generator that delivers electrical signals to the vagus nerve through the lead. The generator is housed in a hermetically sealed titanium case and is powered by a single battery. Electrical signals are transmitted from the generator to the vagus nerve by the lead. The lead and the generator make up the implantable portion of the VNS Therapy System. The VNS Therapy Programming System includes a computer pre-installed with VNS Therapy programming software and a programming wand. The physician uses the programming system to read and change generator settings. The Model 1000 Generator was commercially approved for distribution in the U.S. on October 3, 2017 via PMA P970003/S210. Component: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS).

FDA Enforcement
Class II ·Ongoing·LivaNova USA, Inc.·February 5, 2025